I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 21 studies | 29% ± 11% | |
| classical monocyte | 18 studies | 30% ± 10% | |
| conventional dendritic cell | 16 studies | 29% ± 16% | |
| non-classical monocyte | 16 studies | 30% ± 12% | |
| monocyte | 12 studies | 24% ± 6% | |
| fibroblast | 10 studies | 30% ± 16% | |
| dendritic cell | 8 studies | 34% ± 18% | |
| connective tissue cell | 7 studies | 33% ± 7% | |
| pericyte | 7 studies | 21% ± 4% | |
| endothelial cell | 7 studies | 24% ± 8% | |
| myeloid cell | 7 studies | 26% ± 9% | |
| basal cell | 7 studies | 24% ± 12% | |
| plasmacytoid dendritic cell | 7 studies | 23% ± 6% | |
| smooth muscle cell | 6 studies | 22% ± 4% | |
| epithelial cell | 6 studies | 39% ± 9% | |
| hematopoietic precursor cell | 5 studies | 31% ± 10% | |
| natural killer cell | 5 studies | 19% ± 2% | |
| goblet cell | 5 studies | 29% ± 13% | |
| mesothelial cell | 5 studies | 42% ± 12% | |
| abnormal cell | 5 studies | 30% ± 10% | |
| alveolar macrophage | 4 studies | 28% ± 7% | |
| progenitor cell | 4 studies | 21% ± 9% | |
| myofibroblast cell | 4 studies | 25% ± 6% | |
| erythroblast | 4 studies | 37% ± 6% | |
| neuron | 4 studies | 35% ± 13% | |
| ciliated cell | 4 studies | 24% ± 6% | |
| pancreatic A cell | 3 studies | 38% ± 14% | |
| leukocyte | 3 studies | 21% ± 5% | |
| neural crest cell | 3 studies | 36% ± 3% | |
| extravillous trophoblast | 3 studies | 41% ± 13% | |
| common myeloid progenitor | 3 studies | 33% ± 10% | |
| megakaryocyte | 3 studies | 26% ± 11% | |
| intermediate monocyte | 3 studies | 38% ± 9% | |
| endothelial cell of vascular tree | 3 studies | 21% ± 4% | |
| granulocyte monocyte progenitor cell | 3 studies | 32% ± 6% | |
| hematopoietic stem cell | 3 studies | 29% ± 7% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 53% ± 15% | |
| transit amplifying cell | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 23% ± 8% |
